Cellectis Nom Eo 05 Quote - ALCLS

Your Hub for Real-Time streaming quotes, Ideas and Live Discussions

Premium

Current Price

1.10

Bid

1.10

Ask

1.128

Volume

193,104

1.08 Day's Range 1.198

1.08 52 Week Range 3.025

Market Cap

50.462M

Previous Close

1.18

Open

1.198

Last Trade

1.1

Last Trade Time

Financial Volume

VWAP

Average Volume (3m)

134,015

Shares Outstanding

45,874,895

Dividend Yield

PE Ratio

-1.56

Earnings Per Share (EPS)

-0.8

Revenue

50.07M

Net Profit

-36.76M

Sector

Pharmaceutical Preparations

Industry

Pharmaceutical Preparations

Website

www.cellectis.com

Headquarters

Paris, Paris, Fra

Founded

Cellectis Nom Eo 05 is listed in the Pharmaceutical Preparations sector of the Euronext with ticker ALCLS. The last closing price for Cellectis Nom Eo 05 was 1.18 €. Over the last year, Cellectis Nom Eo 05 shares have traded in a share price range of 1.08 € to 3.025 €.

Cellectis Nom Eo 05 currently has 45,874,895 shares outstanding. The market capitalization of Cellectis Nom Eo 05 is 54.13 € million. Cellectis Nom Eo 05 has a price to earnings ratio (PE ratio) of -1.56.

Cellectis publie ses résultats financiers du quatrième trimestre 2024 et de l’exercice 2024 et une mise à jour de ses activités

Cellectis publie ses résultats financiers du quatrième trimestre 2024 et de l’exercice 2024 et une mise à jour de ses activités ○ UCART22 :...

Period	Change	Change %	Open	High	Low	Avg. Daily Vol	VWAP
1	-0.166	-13.112164297	1.266	1.304	1.08	145931	1.23623239	DE
4	-0.1	-8.33333333333	1.2	1.69	1.08	243222	1.22926158	DE
12	-0.664	-37.641723356	1.764	1.828	1.08	134015	1.31707585	DE
26	-0.704	-39.0243902439	1.804	2.08	1.08	93607	1.45529491	DE
52	-1.51	-57.8544061303	2.61	3.025	1.08	82589	1.80669555	DE
156	-3.348	-75.2697841727	4.448	4.624	0.888	151645	2.51777348	DE
260	-6.71	-85.9154929577	7.81	28.15	0.888	142209	6.1181179	DE

ALCLS - Frequently Asked Questions (FAQ)

What is the current Cellectis Nom Eo 05 share price?

The current share price of Cellectis Nom Eo 05 is 1.10 €

How many Cellectis Nom Eo 05 shares are in issue?

Cellectis Nom Eo 05 has 45,874,895 shares in issue

What is the market cap of Cellectis Nom Eo 05?

The market capitalisation of Cellectis Nom Eo 05 is EUR 54.13M

What is the 1 year trading range for Cellectis Nom Eo 05 share price?

Cellectis Nom Eo 05 has traded in the range of 1.08 € to 3.025 € during the past year

What is the PE ratio of Cellectis Nom Eo 05?

The price to earnings ratio of Cellectis Nom Eo 05 is -1.56

What is the cash to sales ratio of Cellectis Nom Eo 05?

The cash to sales ratio of Cellectis Nom Eo 05 is 1.15

What is the reporting currency for Cellectis Nom Eo 05?

Cellectis Nom Eo 05 reports financial results in USD

What is the latest annual turnover for Cellectis Nom Eo 05?

The latest annual turnover of Cellectis Nom Eo 05 is USD 50.07M

What is the latest annual profit for Cellectis Nom Eo 05?

The latest annual profit of Cellectis Nom Eo 05 is USD -36.76M

What is the registered address of Cellectis Nom Eo 05?

The registered address for Cellectis Nom Eo 05 is 8 RUE DE LA CROIX- JARRY, PARIS, PARIS, 75013

What is the Cellectis Nom Eo 05 website address?

The website address for Cellectis Nom Eo 05 is www.cellectis.com

Which industry sector does Cellectis Nom Eo 05 operate in?

Cellectis Nom Eo 05 operates in the PHARMACEUTICAL PREPARATIONS sector

Most Active
% Gainers
% Losers

Symbol	Price	Vol.
BSGRB&S Group SA	5.85 € (49.43%)	4.24M
SOFTSoftimat sa	1.10 € (40.13%)	3k
ALMCPMcphy Energy	0.46 € (29.94%)	421.79k
MLAATAzorean Tech	0.20 € (29.87%)	498
ALCHIAlchimie	0.38 € (24.18%)	569.74k
TDBSTonner Drones	0.005 € (-24.24%)	704.01k
ALALOAcheterLouerFR	0.001 € (-23.08%)	123.21M
PHXMPHAXIAM Therapeutics SA	0.551 € (-18.37%)	80.77k
VLAValneva SE	2.614 € (-17.59%)	4.43M
ALGIDEgide	0.492 € (-17.45%)	151.17k
ATOAtos SE	0.0038 € (-5.00%)	973.37M
ALCYBCybergun	0.0002 € (0.00%)	310.2M
BCPBanco Comercial Portugues SA	0.49 € (-9.43%)	160.23M
ALVERVergnet	0.0009 € (-10.00%)	139.88M
ALALOAcheterLouerFR	0.001 € (-23.08%)	123.21M

doc2016 4 minutes ago

jensen went to taiwan rather than attend the presentation announcing the stargate project......so now we know what his mission might have been. and this potential would then need to acknowledge that many other players were also 'brought ' in to play their roles early in the game.

NVDA

mankind 5 minutes ago

Just saw this

https://investorshub.advfn.com/uimage/uploads/2025/4/6/biqfggold.png

hedge_fun 5 minutes ago

ACLU Disappointed With Supreme Court's Voter ID Decision

WASHINGTON - In a 6-3 decision, the U.S. Supreme Court today rejected a challenge to Indiana's most-restrictive-in-the-nation voter identification law. The American Civil Liberties Union's case, Crawford v. Marion County Electio

spdpro 5 minutes ago

this is pretty good >
https://www.youtube.com/watch?v=GhDQ2v65m14

eastunder 5 minutes ago

MU, AMD and NVDA (w4/11)

MU cpps 64.72
https://finviz.com/chart.ashx?t=mu&ty=c&ta=1&p=d&s=l

AMD cpps 85.76
https://finviz.com/chart.ashx?t=amd&ty=c&ta=1&p=d&s=l

NVDA cpps 94.30 ( w2b ends 4/11 sold at 108.72) TGT for rebuy
https://fi

AMD NVDA TGT

doc2016 8 minutes ago

nvidia game ip smart antagonist, is called ai boss. see multiple 8 patents but in particular:: from google and justia:
"Patent number 12166923 describes unified communications call routing and decision-making based on an integrated analytics-driven database and aggregated data. An AI boss c

EGHT

bbotcs 9 minutes ago

lj: Remember, alll of the tariffs are negotiable. My guess is that by late Spring, early Summer, the deals will be made and the stock market will begin to recover. But I don't think the big 7 will see their all-time highs for a long while. NVDA at $125 would be satisfactory.
What we reall

NVDA

Wayne R 9 minutes ago

The French abandoned the guillotine a many years ago.

It must be why I 'm surrounded by stupid living here....

Nemesis18 9 minutes ago

the MHRA & FDA have been working together to complete a deep investigative audit of NWBO's previous trials, data produced / submitted and its currently 'on hold' MAA submission.
Would it surprise if criminal charges are brought against key players in this 20 year biotech scam ?
NO !

NWBO

janice shell 10 minutes ago

Well. I suppose that's good to know.

tedpeele 11 minutes ago

Duh. A PDK does not guarantee that it’s going to work the first time in a new foundry. All foundfries are different.

That’s why they couldn’t get the 200 mm to work in anyone other than AMF. Obviously the other foundries tried and couldn’t do it. Maybe by now since they did mention

LWLG

janice shell 11 minutes ago

It isn't at all close for me. Stephanopoulos is right. And his arguments have always been correct. As Rand Paul said, the only other times tariffs this radical have been imposed, they've been followed by economic disaster.

JP Morgan is predicting the sam.

PENNY PIRATE 11 minutes ago

ChanceVision ... Looking Good, Thanks! 😇

AABB

halbroke1 11 minutes ago

Diversified...TWOH $$$ SEEMS ONE OF A KIND....I THINK U MAY BE RIGHT..0.05+ NEXT WEEK IS VERY POSSIBLE!!! WITH 0.25+ BY THE END OF THE MONTH, AND EVENTUALLY BLUE-SKIES TO DOLLARS, IT LOOKS LIKE THINGS ARE HEATING UP BEHIND THE SCENES....THE CHAT-BOARDS ARE GOING CRAZY WITH THIS ONE, " FIREWORKS""..

TWOH

ksquared 12 minutes ago

Nolte: Media Fail — Trump Job Approval Rises 4 Points to 53%
JOHN NOLTE 6 Apr 2025 4:27 They get that “free trade” is not really free when the other side is jamming us with tariffs. They get that if tariffs did not ruin the economies of so many other countries, it’s bizarre t

janetcanada 12 minutes ago

❗️***RDAR ***Opinion vs Knowledge....

☯️***While both opinions and knowledge involve beliefs, knowledge is characterized by being justified and true, while opinions are subjective beliefs that may or may not be based

RDAR

mankind 12 minutes ago

I don't think we've seen capitulation yet. HF's have been dumping heavily in the last few sessions. Once margin calls happen, if not already happening, we should see "Sell what you can, instead of sell what you want". Gold already dipped on Friday and Bitcoin now just broke $80,000. What many forget

misterfishman 13 minutes ago

There's no gold in fort knox not anymore it's all a scam now.

IGPK

Wayne R 13 minutes ago

I certainly hope that 'reading everything ' does not include the internet...🤣

arizona1 13 minutes ago

A Cruel and Frozen Heart: RFK Jr. Decimates LIHEAP Heating Assistance Program

Trump's Health and Human Services Secretary has overseen an attack on the program that helps millions of low-income individuals and families stay warm in winter and cool in summer. Does it get worse than thi

zab 16 minutes ago

The Republicans have reduced themselves to following trump and wherever he goes, they must follow. I have followed my own path and make my decisions along the way. I deal with whoever is in office, that is accomplished by reading everything, and then adapting to changing positions. It's just mon

al44 16 minutes ago

Quite a tidy sum-

https://media.gettr.com/group5/getter/2025/04/06/11/ca89127d-3711-e874-83af-a2108f8a2ef6/989408affea016a6b1b7b22437fda60e_768x0.jpg

OMOLIVES 16 minutes ago

I knew you would. You are one of the few that actually does the research.

HMBL

janetcanada 16 minutes ago

❗️***GRST ***Opinion vs Knowledge....

☯️***While both opinions and knowledge involve beliefs, knowledge is characterized by being justified and true, while opinions are subjective beliefs that may or may not be

GRST

Aimless Blade 18 minutes ago

My biggest fear going forward with this administration/country is that it will see the challenge in building autonomy in semi-conductors, photonics, computing, etc. as a “rare earth” challenge; focusing on mining as the main instrument of “independence”.

There are many interests in th

LWLG

Trending Now

Toplists

Market Data

News

Trading Tools

Markets

Discover

Hot Features

Follow Feed

Options Flow

Monitor

Cellectis Nom Eo 05 (ALCLS) Share Price

Cellectis Nom Eo 05 (ALCLS)

Your Hub for Real-Time streaming quotes, Ideas and Live Discussions

Key stats and details

About Cellectis Nom Eo 05

Ask ADVFN Intelligence (AI)

ALCLS Latest News

Cellectis publie ses résultats financiers du quatrième trimestre 2024 et de l’exercice 2024 et une mise à jour de ses activités

Cellectis Reports Financial Results for the Fourth Quarter and Full Year 2024 and Provides a Business Update

Cellectis Reports Financial Results for the Fourth Quarter and Full Year 2024 and Provides a Business Update

Cellectis to Report Fourth Quarter and Full Year 2024 Financial Results on March 13, 2025

Cellectis publiera ses résultats financiers du quatrième trimestre et de l’année 2024 le 13 mars 2025

Cellectis to Report Fourth Quarter and Full Year 2024 Financial Results on March 13, 2025

Monthly information on share capital and company voting rights

Information mensuelle relative au nombre total des droits de vote et d’actions composant le capital social

Cellectis présente sa stratégie « Smart CAR T » pour améliorer l’efficacité contre les tumeurs solides à l’AACR-IO 2025

Cellectis Presents ‘Smart CAR T’ Strategy to Enhance Efficacy Against Solid Tumors at AACR-IO 2025

Cellectis publie ses résultats financiers du quatrième trimestre 2024 et de l’exercice 2024 et une mise à jour de ses activités

Cellectis Reports Financial Results for the Fourth Quarter and Full Year 2024 and Provides a Business Update

Cellectis Reports Financial Results for the Fourth Quarter and Full Year 2024 and Provides a Business Update

Cellectis to Report Fourth Quarter and Full Year 2024 Financial Results on March 13, 2025

Cellectis to Report Fourth Quarter and Full Year 2024 Financial Results on March 13, 2025

Cellectis publiera ses résultats financiers du quatrième trimestre et de l’année 2024 le 13 mars 2025

Monthly information on share capital and company voting rights

Information mensuelle relative au nombre total des droits de vote et d’actions composant le capital social

Cellectis Presents ‘Smart CAR T’ Strategy to Enhance Efficacy Against Solid Tumors at AACR-IO 2025

Cellectis Presents ‘Smart CAR T’ Strategy to Enhance Efficacy Against Solid Tumors at AACR-IO 2025

Cellectis présente sa stratégie « Smart CAR T » pour améliorer l’efficacité contre les tumeurs solides à l’AACR-IO 2025

Information mensuelle relative au nombre total des droits de vote et d’actions composant le capital social

ALCLS - Frequently Asked Questions (FAQ)

Movers

Discussion

Your Recent History

Company

Business

Popular

Get The App

Go Ad-Free